Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 23;14(3):51.
doi: 10.3390/biotech14030051.

Expression and Biological Activity Analysis of Recombinant Fibronectin3 Protein in Bacillus subtilis

Affiliations

Expression and Biological Activity Analysis of Recombinant Fibronectin3 Protein in Bacillus subtilis

Chaozheng Lu et al. BioTech (Basel). .

Abstract

Fibronectin (FN), a primary component of the extracellular matrix (ECM), features multiple structural domains closely linked to various cellular behaviors, including migration, spreading, adhesion, and proliferation. The FN3 domain, which contains the RGD sequence, is critical in tissue repair because it enables interaction with integrin receptors on the cell surface. However, the large molecular weight of wild-type FN presents challenges for its large-scale production through heterologous expression. Therefore, this study focused on cloning the FN3 functional domain of full-length FN for expression and validation. This study selected Bacillus subtilis as the expression host due to its prominent advantages, including efficient protein secretion, absence of endotoxins, and minimal codon bias. The recombinant vector pHT43-FN3 was successfully constructed through homologous recombination technology and transformed into Bacillus subtilis WB800N. The FN3 protein was successfully expressed after induction with IPTG. Following purification of the recombinant FN protein using a His-tag nickel column, SDS-PAGE analysis showed that the molecular weight of FN3 was approximately 27.3 kDa. Western blot analysis confirmed the correct expression of FN3, and the BCA protein assay kit determined a protein yield of 5.4 mg/L. CCK8 testing demonstrated the good biocompatibility of FN3. In vitro cell experiments showed that FN3 significantly promoted cell migration at a 20 μg/mL concentration and enhanced cell adhesion at 10 μg/mL. In summary, this study successfully utilized Bacillus subtilis to express the FN3 functional domain peptide from FN protein and has validated its ability to promote cell migration and adhesion. These findings not only provide a strategy for the expression of FN protein in B. subtilis, but also establish an experimental foundation for the potential application of FN3 protein in tissue repair fields such as cutaneous wound healing and cartilage regeneration.

Keywords: Bacillus subtilis; cell adhesion; cell migration; recombinant fibronectin3 protein.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Construction process and PCR verification of pHT43-FN3. (A) Preparation of the recombinant plasmid pHT43-FN3. (B) PCR amplification of the FN3 fragment. (C) Single-enzyme digestion of the pHT43 vector. (D) Colony PCR fragments of the pHT43-FN3 recombinant strain.
Figure 2
Figure 2
Bioinformatics prediction of FN3 and optimization of fermentation conditions. (A) Functional domain prediction of recombinant FN3. (B) Structural prediction of recombinant FN3. (C) SDS-PAGE electrophoresis of pellet and supernatant from recombinant B. subtilis before and after induction. M: protein marker; 1: bacterial culture before induction; 2: bacterial cells after induction; 3–5: fermentation supernatants at 28 °C with IPTG induction concentrations of 0.1, 0.5, and 1 mM in sequence; 6–8: fermentation supernatants at 37 °C with IPTG induction concentrations of 0.1, 0.5, and 1 mM in sequence.
Figure 3
Figure 3
SDS-PAGE electrophoretogram of recombinant FN3 after ammonium sulfate precipitation and purification. (A) The fermentation supernatant was subjected to ammonium sulfate precipitation. M: protein marker; lanes 1–6: fermentation supernatants precipitated with 20%, 30%, 40%, 50%, 60%, and 70% ammonium sulfate, respectively. (B) The target protein was purified by a His-tag nickel column. M: protein marker; 1: flow-through fraction; 2–4: the 1st–3rd tubes of the eluent containing impurity proteins eluted with 3 mM imidazole in sequence; 5–12: The 1st–8th tubes of the eluent containing the target protein eluted with 50 mM imidazole in sequence.
Figure 4
Figure 4
Western blot of recombinant FN3 protein. 1: empty vector negative control; 2–4: purified FN3 protein.
Figure 5
Figure 5
FN3 induces concentration-dependent effects on the viability of L-929 cells. ns p > 0.05 denotes a non-significant difference between the experimental and control groups, n = 6.
Figure 6
Figure 6
Effect of FN3 on the migration of L-929 cells. (A) The migration area of L-929 cells at different time points (×200). (B) The relative quantitative assessment of the migration area in L-929. * p < 0.05 shows a significant difference between the experimental and control groups; ** p < 0.01, *** p < 0.001, **** p <0.0001 show a highly significant difference between the experimental and control groups, n = 3.
Figure 7
Figure 7
Detection of the adhesion effect of recombinant FN protein on L-929 cells by crystal violet staining. (A) cell images stained with crystal violet (×200). (B) Quantification of adhered cells. *** p < 0.001, **** p < 0.0001 indicate a highly significant difference between the experimental and control groups, n = 3.

Similar articles

  • The Black Book of Psychotropic Dosing and Monitoring.
    DeBattista C, Schatzberg AF. DeBattista C, et al. Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
  • Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T, Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Leeflang MM, Spijker R, Hooft L, Emperador D, Domen J, Tans A, Janssens S, Wickramasinghe D, Lannoy V, Horn SRA, Van den Bruel A; Cochrane COVID-19 Diagnostic Test Accuracy Group. Struyf T, et al. Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
  • Systemic Inflammatory Response Syndrome.
    Baddam S, Burns B. Baddam S, et al. 2025 Jun 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jun 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31613449 Free Books & Documents.
  • Short-Term Memory Impairment.
    Cascella M, Al Khalili Y. Cascella M, et al. 2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31424720 Free Books & Documents.
  • Sertindole for schizophrenia.
    Lewis R, Bagnall AM, Leitner M. Lewis R, et al. Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2. Cochrane Database Syst Rev. 2005. PMID: 16034864 Free PMC article.

References

    1. Morrison P.R., Edsall J.T., Miller S.G. Preparation and properties of serum and plasma proteins. XVIII. The separation of purified fibrinogen from fraction I of human plasma. J. Am. Chem. Soc. 1948;70:3103–3108. doi: 10.1021/ja01189a080. - DOI - PubMed
    1. Theocharis A.D., Skandalis S.S., Gialeli C., Karamanos N.K. Extracellular matrix structure. Adv. Drug. Deliv. Rev. 2016;97:4–27. doi: 10.1016/j.addr.2015.11.001. - DOI - PubMed
    1. Mao Y., Schwarzbauer J.E. Fibronectin fibrillogenesis, a cell-mediated matrix assembly process. Matrix Biol. 2005;24:389–399. doi: 10.1016/j.matbio.2005.06.008. - DOI - PubMed
    1. Gui L., Wojciechowski K., Gildner C.D., Nedelkovska H., Hocking D.C. Identification of the heparin-binding determinants within fibronectin repeat III1: Role in cell spreading and growth. J. Biol. Chem. 2006;281:34816–34825. doi: 10.1074/jbc.M608611200. - DOI - PubMed
    1. Jarnagin W.R., Rockey D.C., Koteliansky V.E., Wang S.S., Bissell D.M. Expression of variant fibronectins in wound healing: Cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J. Cell Biol. 1994;127:2037–2048. doi: 10.1083/jcb.127.6.2037. - DOI - PMC - PubMed

LinkOut - more resources